• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Continuous glucose monitoring associated with better glucose control for patients receiving insulin for type 2 diabetes

byCaitlyn HuiandDeepti Shroff Karhade
August 24, 2017
in Chronic Disease, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Continuous glucose monitoring in type 2 diabetes patients was associated with improved glycemic control.

2. No significant difference in quality-of-life was observed in patients using continuous glucose monitoring.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Continuous glucose monitoring (CGM) has been well studied in type 1 diabetes patients; however, little data exists regarding its efficacy in patients with type 2 diabetes. With CGM, glucose readings are provided every 5 minutes, in addition to low and high glucose alerts and glucose trend information. The authors of this study aimed to determine the effectiveness of CGM in type 2 diabetic adults that receive multiple injections of insulin on a daily basis. In general, the results of the study suggested that type 2 diabetes patients using CGM have improved glycemic control. The main limitation of the study is that follow-up was restricted to 6 months. As a result, the long-term effects of CGM are unclear. Overall, the results of this study indicate that CGM could be beneficial for adults with type 2 diabetes who are receiving daily insulin injections.

Click to read the study, published in the Annals of Internal Medicine

Relevant Reading: The Use of Continuous Glucose Monitoring in Patients with Type 2 Diabetes

In-Depth [randomized controlled trial]: In this randomized clinical trial, a total of 158 adult patients were divided into 2 arms: usual care or CGM. Patients had had type 2 diabetes for a median of 17 years and were receiving multiple daily injections of insulin. While the two patient cohorts did not differ significantly with respect to quality-of-life outcomes or CGM-measured hypoglycemia, the CGM group had improved glucose control. Specifically, the mean HbA1c levels in the intervention group decreased to 7.7%, compared to the control group where they only decreased to 8.0% at 24 weeks (adjusted difference in mean change, -0.3% [95% CI, -0.5% to 0.0%]; p = 0.022).

RELATED REPORTS

Vitamin D effective in preventing the progression of pre-diabetes to diabetes

Exercise improves outcomes in patients with cardiovascular disease

Wellness Check: Exercise

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: blood glucosetype 2 diabetes
Previous Post

Extensive cancer screening may not improve outcomes for patients with unprovoked venous thromboembolism

Next Post

Risk of cardiovascular events similar between degludec and glargine in type 2 diabetics: The DEVOTE trial

RelatedReports

Vitamin deficiency may persist after Omega-loop gastric bypass
Cardiology

Vitamin D effective in preventing the progression of pre-diabetes to diabetes

February 14, 2023
Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Cardiology

Exercise improves outcomes in patients with cardiovascular disease

February 8, 2023
Few older adolescents meet recommended levels of physical activity
Wellness

Wellness Check: Exercise

February 2, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
Next Post
Type 2 diabetes associated with reduction in disability-free life years

Risk of cardiovascular events similar between degludec and glargine in type 2 diabetics: The DEVOTE trial

Factors contributing to parents providing alcohol sips to adolescents

2 Minute Medicine Rewind August 21, 2017

Severity of emphysema on pulmonary CT may predict lung cancer location

Small-molecule inhibitor may reduce chemotherapy-associated metastases [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options